子宫内膜消融市场规模、份额和增长分析（按产品、最终用途和地区）- 行业预测 2025-2032

Endometrial Ablation Market Size, Share, and Growth Analysis, By Product (Cryoablation, Radiofrequency Ablation), By End-use (Hospitals, Clinics), By Region - Industry Forecast 2025-2032

出版日期: 2025年02月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年子宫内膜消融市场规模价值 20.7 亿美元，预计将从 2024 年的 22 亿美元增长到 2032 年的 35.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.1%。

由于妇科疾病（例如月经、多囊性卵巢症候群、异常阴道出血等）的盛行率不断上升，以及人们对这些手术的益处的认识不断提高，子宫内膜消融手术和设备市场正在经历显着增长。每年约有 1000 万美国女性受到经痛的影响，全球 3%-30% 的育龄妇女患有异常子宫出血 (AUB)，因此对可月经降低风险和併发症的微创手术的需求日益增长。政府和私人医疗机构都将女性健康放在首位，印度等国家正在实施医疗保险免税等倡议，以鼓励女性接受治疗。儘管该手术存在潜在风险，但 AUB 的持续流行表明市场对有效解决方案的需求永续。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司详细信息
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Hologic, Inc.（United States）
Boston Scientific Corporation（United States）
Medtronic plc（Ireland）
CooperSurgical Inc.（United States）
Olympus Corporation（Japan）
Smith & Nephew plc（United Kingdom）
Minerva Surgical, Inc.（United States）
Ethicon, Inc.（Johnson & Johnson）（United States）
AngioDynamics, Inc.（United States）
Myosure（Hologic, Inc.）（United States）

结论和建议

简介目录

Product Code: SQMIG35A2573

Endometrial Ablation Market size was valued at USD 2.07 billion in 2023 and is poised to grow from USD 2.20 billion in 2024 to USD 3.53 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The market for endometrial ablation procedures and devices is witnessing significant growth due to the rising incidence of gynecological disorders such as menorrhagia, PCOD, and abnormal vaginal bleeding, coupled with increased awareness of the benefits these procedures offer. With approximately 10 million American women affected by menorrhagia each year, along with 3 to 30% of reproductive-aged women globally experiencing Abnormal Uterine Bleeding (AUB), the demand for minimally invasive techniques that minimize risk and complexity is on the rise. Governments and private health organizations are prioritizing women's health, implementing initiatives like tax exemptions for health insurance in countries like India to encourage treatment adoption. Despite potential risks associated with the procedures, the consistent prevalence of AUB underscores a sustainable demand for effective solutions in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Endometrial Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Endometrial Ablation Market Segments Analysis

Global Endometrial Ablation Market is segmented by Product, End-use and region. Based on Product, the market is segmented into Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon, Microwave Energy and Others. Based on End-use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Endometrial Ablation Market

The rise in the prevalence of gynecological conditions, including menorrhagia, abnormal vaginal bleeding, and polycystic ovary syndrome (PCOS), significantly propels the growth of the endometrial ablation market. As these disorders become more common, there is an escalating need for effective and minimally invasive treatment alternatives, prompting patients and healthcare providers to seek solutions such as endometrial ablation. This growing awareness and demand for less invasive procedures not only highlight the urgency of addressing these health issues but also contribute to the overall expansion of the endometrial ablation market, making it a key area of focus for medical professionals and manufacturers alike.

Restraints in the Endometrial Ablation Market

The endometrial ablation market faces several restraints due to the procedure's limitations and associated risks. Not every patient is a suitable candidate for endometrial ablation, and the potential for complications can deter both patients and practitioners from pursuing this treatment option. Adverse effects such as infections, accidental tearing of the uterine wall or bowel, and other unintended outcomes may further restrict market expansion. As a result, these factors contribute to hesitancy and reluctance toward the adoption of endometrial ablation procedures, ultimately impacting the overall growth potential of the market in the healthcare landscape.

Market Trends of the Endometrial Ablation Market

The endometrial ablation market is witnessing a robust trend driven by rapid technological advancements, which are revolutionizing the landscape of minimally invasive gynecological procedures. Innovative devices boasting enhanced precision, safety, and efficacy are emerging, thus appealing to both patients seeking effective solutions for abnormal uterine bleeding and healthcare professionals desiring improved surgical outcomes. These advancements, including advanced energy-based techniques and real-time imaging, are contributing to higher patient satisfaction rates and fostering broader acceptance of these procedures within clinical settings. As a result, the market is poised for significant growth, bolstered by a heightened emphasis on women's health and patient-centered care solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Analysis

Global Endometrial Ablation Market Size by Product & CAGR (2025-2032)

Market Overview
Cryoablation
Radiofrequency Ablation
Hydrothermal Ablation
Thermal Balloon
Microwave Energy
Others

Global Endometrial Ablation Market Size by End-use & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers

Global Endometrial Ablation Market Size & CAGR (2025-2032)

North America (Product, End-use)
- US
- Canada
Europe (Product, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minerva Surgical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon, Inc. (Johnson & Johnson) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myosure (Hologic, Inc.) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments